| Literature DB >> 35012904 |
Abstract
Liver cancer burden varies greatly among populations. This disparity stems from the presence of complex etiology, sex, race/ethnicity, and extensive tumor molecular heterogeneity. Our ability to dissect tumor heterogeneity and to identify shared common features of liver cancer in diverse populations may improve precision medicine, thereby reducing disease burden.Entities:
Keywords: health disparity; health equity; hepatocellular carcinoma; liver cancer; precision medicine; tumor heterogeneity
Mesh:
Year: 2022 PMID: 35012904 PMCID: PMC9058969 DOI: 10.1016/j.trecan.2021.12.001
Source DB: PubMed Journal: Trends Cancer ISSN: 2405-8025